Genomic Vision S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GV.PA research report →
About the company
Headquartered in Bagneux, France, and established in 2004, Genomic Vision S. A. is a molecular diagnostics and technology company focused on developing sophisticated tools for analyzing individual DNA molecules.
- CEO
- Aaron Bensimon
- IPO
- 2014
- Employees
- 33
- HQ
- Bagneux, FR
Price Chart
- Market Cap
- $693.19K
- P/E
- -0.04
- P/S
- 0.47
- P/B
- -0.19
- EV/EBITDA
- -0.44
- Div Yield
- 0.00%
- Gross Margin
- 86.01%
- Op Margin
- -413.65%
- Net Margin
- -457.84%
- ROE
- -760.92%
- ROIC
- -440.47%
- Revenue
- $1.48M · 4.74%
- Net Income
- $-6,776,000 · -35.57%
- EPS
- $-0.05 · 50.00%
- Op Income
- $-6,122,000
- FCF YoY
- 2.25%
- 52W High
- $0.09
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.01
- Beta
- -0.67
- Avg Volume
- 14.22M
Get TickerSpark's AI analysis on GV.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our GV.PA coverage
Recent articles, reports, and earnings notes.
No research on GV.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GV.PA report →Similar companies
Peers in the same neighborhood.